Compare BTI & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTI | SNPS |
|---|---|---|
| Founded | 1902 | 1986 |
| Country | United Kingdom | United States |
| Employees | 50290 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.8B | 96.6B |
| IPO Year | N/A | 1994 |
| Metric | BTI | SNPS |
|---|---|---|
| Price | $62.32 | $453.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $62.00 | ★ $540.71 |
| AVG Volume (30 Days) | ★ 3.7M | 1.8M |
| Earning Date | 02-12-2026 | 05-27-2026 |
| Dividend Yield | ★ 5.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $5,081,542,000.00 |
| Revenue This Year | $3.72 | $39.22 |
| Revenue Next Year | $3.56 | $10.73 |
| P/E Ratio | ★ $12.53 | $1,060.86 |
| Revenue Growth | N/A | ★ 20.87 |
| 52 Week Low | $46.38 | $376.18 |
| 52 Week High | $67.30 | $651.65 |
| Indicator | BTI | SNPS |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 38.51 |
| Support Level | $56.20 | $413.59 |
| Resistance Level | $62.63 | $488.81 |
| Average True Range (ATR) | 1.18 | 22.01 |
| MACD | -0.19 | -7.01 |
| Stochastic Oscillator | 51.51 | 9.10 |
The third-largest tobacco company by volume, British American Tobacco sold 465 billion cigarettes in 2025. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.